These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3111900)

  • 21. [Serologic Rh incompatibility in the presence or absence of antigenic incompatibility of the ABO system].
    Kotzbach R; Szymański W
    Ginekol Pol; 1986 Oct; 57(10):646-9. PubMed ID: 3102319
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on fetal physiology and pathophysiology in rhesus disease.
    Nicolaides KH
    Semin Perinatol; 1989 Aug; 13(4):328-37. PubMed ID: 2528210
    [No Abstract]   [Full Text] [Related]  

  • 23. [Critical comments on the current treatment of neonatal hemolytic diseases due to anti-Rh(D) isoimmunization].
    Velcovici D; Grigoriu G
    Rev Pediatr Obstet Ginecol Pediatr; 1986; 35(4):345-59. PubMed ID: 3105027
    [No Abstract]   [Full Text] [Related]  

  • 24. Antenatal serologic assessment of severity of hemolytic disease due to anti-Rh.
    Frankowska K
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):613-9. PubMed ID: 5006484
    [No Abstract]   [Full Text] [Related]  

  • 25. Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy.
    Elasoud K; McClure G; Halliday HL; Dornan JC
    Ulster Med J; 1997 May; 66(1):62-4. PubMed ID: 9185494
    [No Abstract]   [Full Text] [Related]  

  • 26. Rescue in inner space: management of Rh hemolytic disease.
    Liley HG
    J Pediatr; 1997 Sep; 131(3):340-2. PubMed ID: 9329405
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of severe red cell immunization in pregnancy.
    Kanhai HH
    Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42 Suppl():S90-5. PubMed ID: 1809617
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-Rh32 causing severe hemolytic disease of the newborn.
    Orlina AR; Unger PJ; Lacey PA
    Rev Fr Transfus Immunohematol; 1984 Oct; 27(5):613-8. PubMed ID: 6441229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemosorption in the prevention of severe forms of hemolytic disease of the newborn in rhesus sensitization].
    Konopliannikov AG; Saĭkina EA; Goriushina NB; Panina OB
    Akush Ginekol (Mosk); 1993; (6):31-3. PubMed ID: 8311153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].
    Lozińska D; Radomska I; Samborska K; Dmoch E; Garwoliński J; Lenkiewicz B; Góralski T
    Pol Tyg Lek; 1988 Nov; 43(45):1449-51. PubMed ID: 3151013
    [No Abstract]   [Full Text] [Related]  

  • 31. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-C(w) alloimmunization presenting as hydrops fetalis.
    Kollamparambil TG; Jani BR; Aldouri M; Soe A; Ducker DA
    Acta Paediatr; 2005 Apr; 94(4):499-501. PubMed ID: 16092467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is hypoglycemia an important complication in erythroblastosis fetalis?
    Lucey JF; Randall JL; Murray JJ
    Am J Dis Child; 1967 Jul; 114(1):88-90. PubMed ID: 5006444
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience with the use of ziksorin in hemolytic disease of newborn infants].
    Panchenko AI; Kalinicheva VI; Bashnina EB; Monastyrenko AIa; Potapova VP
    Pediatriia; 1988; (6):77-80. PubMed ID: 3141898
    [No Abstract]   [Full Text] [Related]  

  • 35. [Infection risk factors in newborn infants with fetal erythroblastosis].
    Maszkiewicz W; Ornat K; Laskowska B; Irzyńska D; Manerowska D
    Acta Haematol Pol; 1988; 19(3-4):230-8. PubMed ID: 3150899
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serious materno-fetal alloimmunization: about a case and review of the literature].
    Zineb B; Boutaina L; Ikram L; Driss MR; Mohammed D
    Pan Afr Med J; 2015; 22():137. PubMed ID: 26889318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
    Lobato G; Nakamura-Pereira M
    Fetal Diagn Ther; 2008; 24(4):474-7. PubMed ID: 19047795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound-guided fetal intravascular transfusion in severe rhesus immunization.
    Seeds JW; Bowes WA
    Am J Obstet Gynecol; 1986 May; 154(5):1105-7. PubMed ID: 3085503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989.
    Hussey RM; Clarke CA
    BMJ; 1991 Aug; 303(6800):445-6. PubMed ID: 1912836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.